Who Paid My Doc
Martin Paukert
Plastic and Reconstructive Surgery Saint Helena, CA Medical Doctor
NPI 1477719326 CMS profile 860452
6 Woodland Rd, Suite 302, Saint Helena, CA 94574
General payments
$3,373
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Martin Paukert of Saint Helena, CA is reported in the CMS Open Payments database as having received $3,373 across 198 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 60th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,718 | 103 | |
| 2024 | General | $1,085 | 69 | |
| 2023 | General | $134 | 4 | |
| 2022 | General | $164 | 8 | |
| 2021 | General | $95 | 5 | |
| 2020 | General | $38 | 2 | |
| 2019 | General | $140 | 7 |
Beside peers
- Martin Paukert
- Plastic and Reconstructive Surgery median
- Middle half of Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to Martin Paukert were reported at $1,718. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.
Show as a table
| Year | Martin Paukert | Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $140 | $335 | $121–$1,264 | $163 |
| 2020 | $38 | $162 | $57–$417 | $114 |
| 2021 | $95 | $245 | $89–$735 | $132 |
| 2022 | $164 | $325 | $120–$932 | $149 |
| 2023 | $134 | $343 | $129–$999 | $160 |
| 2024 | $1,085 | $390 | $141–$1,085 | $164 |
| 2025 | $1,718 | $442 | $150–$1,242 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 8 drugsPart D claims
276
Drug cost
$2,260
Branded share of claims
64.9%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 94 | $865 | |
| Ibuprofen | Generic | 48 | $388 | |
| Ondansetron Odt Ondansetron | Brand | 53 | $353 | |
| Doxycycline Hyclate | Generic | 21 | $253 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 18 | $132 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 14 | $121 | |
| Levofloxacin | Generic | 11 | $74 | |
| Cephalexin | Generic | 17 | $74 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,638 Part D prescribers listed as Plastic and Reconstructive Surgery; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 125 billing codesPaid by Medicare
$1,057,058
Medicare patients
267
Services billed
7,275
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 56% | |
| Diabetes | 38% | |
| Ischemic heart disease | 30% | |
| Atrial fibrillation | 27% | |
| Heart failure | 26% | |
| COPD | 26% | |
| Chronic kidney disease | 25% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Epifix, per square centimeter Q4186 | Office | 31 | 4,466 | $533,686 |
| Injection, dexamethasone sodium phosphate, 1 mg J1100 | Office | 21 | 132 | $12 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
198 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Plastic and Reconstructive Surgery in California
Practitioners in the same specialty and state, ranked by reported value.
All Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.